Consulting Reference Information
8-3
P/N 85213-30, Manual revision: B
Table 8-1, AC solution concentration in MCS+ final collection products
AC Ratio
1:8
1:9
1:10
1:11
1:12
1:16
Donor
Hematocrit
% Anticoagulant in the plasma or platelet product
20
15.2
13.5
12.2
11.1
10.2
7.7
22
15.5
13.8
12.5
11.4
10.4
7.9
24
15.8
14.1
12.8
11.6
10.7
8.1
26
16.2
14.5
13.1
11.9
10.9
8.3
28
16.6
14.8
13.4
12.2
11.2
8.5
30
16.9
15.2
13.7
12.5
11.5
8.7
32
17.4
15.5
14.0
12.8
11.8
8.9
34
17.8
15.9
14.4
13.2
12.1
9.2
36
18.2
16.3
14.8
13.5
12.4
9.4
37
18.5
16.6
15.0
13.7
12.6
9.6
38
18.7
16.8
15.2
13.9
12.8
9.7
39
19.0
17.0
15.4
14.1
13.0
9.9
40
19.2
17.2
15.6
14.3
13.2
10.0
41
19.5
17.5
15.8
14.5
13.4
10.2
42
19.8
17.7
16.1
14.7
13.6
10.3
43
20.0
18.0
16.3
14.9
13.8
10.5
44
20.3
18.2
16.6
15.2
14.0
10.6
45
20.6
18.5
16.8
15.4
14.2
10.8
46
20.9
18.8
17.1
15.6
14.4
11.0
47
21.2
19.1
17.3
15.9
14.6
11.2
48
21.6
19.4
17.6
16.1
14.9
11.4
49
21.9
19.7
17.9
16.4
15.1
11.6
50
22.2
20.0
18.2
16.7
15.4
11.8
60
26.3
23.8
21.7
20.0
18.5
14.3
Содержание MCS+
Страница 2: ...2002 2006 Haemonetics Corporation All rights reserved...
Страница 10: ...x Preface P N 85213 30 Manual revision B The Haemonetics MCS LN09000 220E ED...
Страница 20: ......
Страница 30: ......
Страница 81: ...Maintaining the MCS Equipment 5 7 P N 85213 30 Manual revision B...
Страница 85: ......
Страница 86: ...5 12 Maintaining the MCS Equipment P N 85213 30 Manual revision B...
Страница 100: ......
